filmov
tv
From Biotech to Asset Management with Sunaina Sinha | Masters in Business
Показать описание
Barry speaks with Sunaina Sinha, Global Head of Private Capital Advisory at Raymond James. Prior to joining Raymond James, Sunaina founded Cebile Capital, which was acquired by Raymond James in 2021. She was named one of the 50 Most Influential People in Private Equity for 2 years in a row by Dow Jones Private Equity News. She also earned a spot as one of the Twenty Trailblazing Women in Private Equity in 2023. Additionally, Sunaina serves as Chairman of the Board of Directors of SFC Energy AG and on the boards of the Stanford Institution for Economic Policy Research and the Stanford LEAD Council.
Bloomberg Radio host columnist Barry Ritholtz looks at the people and ideas that shape markets, investing and business.
Visit our other YouTube channels:
#Business #Investing #Podcast
Bloomberg Radio host columnist Barry Ritholtz looks at the people and ideas that shape markets, investing and business.
Visit our other YouTube channels:
#Business #Investing #Podcast
From Biotech to Asset Management with Sunaina Sinha | Masters in Business
Leading with science: A deep dive on biotech
BB Biotech – equity proposition
Is Biotech in a Bubble?
How Hong Kong became a leading hub for biotech growth
Biotech funding has been an issue in the pharmaceutical industry, says Novo Holdings partner
Money Management : Researching Biotechnology Stocks
Biotech and Big Pharma: Blueprint for Successful Partnership - Season 1 Episode 8
Trinity Biotech’s EpiCapture: A New Era in Prostate Cancer Diagnostics
Biotech IPOs: New Steps to Success on the Road to Going Public - Season 1 Episode 1
Strategic Portfolio Management for Biotech Pharma
How to play biotech stocks: Emerald Advisors
KEYNOTE: IMPLEMENTING PORTFOLIO MANAGEMENT AND RESOURCE MANAGEMENT IN BIOTECH
Cathie Wood's Latest Investments in Biotech Stocks: Should You Follow Suit?
Biotech SPACs: A New Route to Going Public - Season 1 Episode 5
Why Biotech and Life Sciences?
The Biotech Growth Trust in 60 seconds
Biotechnology & Healthcare: A New Dawn? - With Bob Bradway, CEO of Amgen
Investor Watch | Biotech Hedge Fund Losses Mount but Enormous Sums of Capital Available
A Self-Made Billionaires Journey from Biotech to Politics
Inside Track: Behind the Scenes of a Major Biotech SPAC - Season 1 Episode 6
Melbourne Biotech: Transforming Solid Tumour Therapy with Cutting-Edge Immunotherapy
Biotech Investors: How to Find Value in a Bear Market - Season 2 Episode 1
Decoding Biotech Investing | Sara Nunez-Garcia | Prof Claudia Zeisberger
Комментарии